SEARCH

SEARCH BY CITATION

References

  • 1
    Recommendations of the Advisory Committee on Immunization Practices (ACIP). Measles, mumps and rubella—Vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps. MMWR Morb Mortal Wkly Rep Recomm Rep 1998; 47: 148.
  • 2
    Health Protection Agency. Indications and dosage for normal and specific immunoglobulin preparations issued by the Health Protection Agency. In: Immunoglobulin Handbook. Revised Ed. [Online]. 2004 [cited 2004 Jul 12];[28 screens]. Available from: URL: http://www.hpa.org.uk/infections/topics_az/immunoglobulin/pdfs/ig_handbook120704.pdf
  • 3
    Hutchins SS, Papania MJ, Amler R et al. Evaluation of the measles clinical case definition. J Infect Dis 2004; 189(Suppl 1): S153S159.
  • 4
    Mustafa MM, Weitman SD, Winick NJ, Bellini WJ, Timmons CF, Siegel JD. Subacute measles encephalitis in the young immunocompromised host: Report of two cases diagnosed by polymerase chain reaction and treated with Ribavirin and review of the literature. Clin Infect Dis 1993; 16: 654660.
  • 5
    Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA 1992; 267: 12371241.
  • 6
    Health Protection Agency. Laboratory confirmed cases of measles, mumps, and rubella, England and Wales: April to June 2003. Commun Dis Rep CDR Wkly [serial online] 2003 [cited 2003 Sept 25]; 13(39): [21 screens]. Available from: URL: http://www.hpa.org.uk/cdr/archives/2003/cdr3903.pdf
  • 7
    Cock HR, Shorvon SD. The spectrum of epilepsy and movement disorders in EPC. In: GuerriniR, AicardiJ, AndermannF, HallettM, eds. Epilepsy and Movement Disorders. Cambridge : Cambridge University Press, 2002: 211226.
  • 8
    Agamanolis DP, Tan JS, Parker DL. Immunosuppressive measles encephalitis in a patient with a renal transplant. Arch Neurol 1979; 36: 686690.
  • 9
    Klapper PE, Cleator GM, Clarke MC, Postlethwaite RJ. Measles immunization. Arch Dis Child 1991; 66: 369.
  • 10
    Kalman S, Bakkaloglu SA, Özkaya O, Buyan N, Soylemezoglu O. Measles: A rare communicable disease in a child with renal transplantation. Pediatr Transplant 2002; 6: 432434.
  • 11
    Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte HJ. Response to measles-mumps-rubella vaccine in children on dialysis. Pediatr Nephrol 1992; 6: 187189.
  • 12
    Laube GF, Berger C, Goetschel P, Leumann E, Neuhaus TJ. Immunization in children with chronic renal failure. Pediatr Nephrol 2002; 17: 638642.
  • 13
    Health Protection Agency. Confirmed cases of measles by region and age: 1996–2004. 2005 [cited 2005 June 23]. Available from: URL: http://www.hpa.org.uk/infections/topics_az/measles/data_reg_age.htm
  • 14
    Jansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, Rhodes CJ. Measles outbreaks in a population with declining vaccine uptake. Science 2003; 301: 804.
  • 15
    Kidd IM, Booth CJ, Rigden SPA, Tong CYW, MacMahon EM. Measles-associated encephalitis in children with renal transplants: A predictable effect of waning herd immunity? Lancet 2003; 362: 832.
  • 16
    Freeman AF, Jacobsohn DA, Shulman ST et al. A new complication of stem cell transplantation: Measles inclusion body encephalitis. Pediatrics 2004; 114: e657e660.
  • 17
    Hannon F-X, Spika John J, Wassilak Steven S, Emiroglu N. Short report. WHO European Region's strategy for elimination of measles and congenital rubella infection. Euro Surveill 2003; 8: 128129.
  • 18
    Stark K, Günther M, Schönfeld C, Tullius SG, Bienzle U. Immunizations in solid-organ transplant recipients. Lancet 2002; 359: 957965.